A carregar...
Patient Cost Sharing and Receipt of Erythropoiesis-Stimulating Agents Through Medicare Part D
PURPOSE: Medicare Part D prescription benefits cover injected medications, normally covered under Part B, when administered outside of physician offices. Erythropoiesis-stimulating agents (ESAs) used for chronic anemia management in patients with myelodysplastic syndromes (MDS) are commonly injected...
Na minha lista:
| Publicado no: | J Oncol Pract |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Clinical Oncology
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4371123/ https://ncbi.nlm.nih.gov/pubmed/25563701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2014.001527 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|